Taylor & Francis Group

SHERPA: Unknown

People

  1. Geyer
    Geyer
  2. Tallman
    Tallman
  3. Goldberg
    Goldberg
  4. Derkach
    Derkach
  5. Park
    Park
  6. Stein
    Stein
  7. Giralt
    Giralt
  8. Kumar
    Kumar
  9. Epstein-Peterson
    Epstein-Peterson
  10. Famulare
    Famulare

Groups

  1. Hematology-Oncology Fellows (24)
  2. Weinberg Fellows (24)
  3. Department of Medicine (23)
  4. Center for Hematologic Malignancies (22)
  5. Hematologic Malignancies, Division of (22)
  6. Adult Leukemia (16)
  7. Population Sciences Research Program (9)
  8. GME, Medicine (8)
  9. Graduate Medical Education (8)
  10. Epidemiology and Biostatistics (7)
Search Within
  1. "Weinberg Fellows"
Formats
  1. Journal Article (14)
  2. Review (4)
  3. Research Letter (3)
  4. Correspondence (1)
  5. Editorial (1)
  6. Meeting Abstract (1)
Groups
  1. Hematology-Oncology Fellows (24)
  2. Weinberg Fellows (24)
  3. Department of Medicine (23)
  4. Center for Hematologic Malignancies (22)
  5. Hematologic Malignancies, Division of (22)
  6. Adult Leukemia (16)

More Groups

People
  1. Mark Geyer (9)
  2. Martin Tallman (9)
  3. Aaron Goldberg (8)
  4. Andriy Derkach (5)
  5. Eytan Stein (5)
  6. Jae Park (5)

More People

Years
  1. 2025 (2)
  2. 2024 (2)
  3. 2023 (2)
  4. 2022 (3)
  5. 2021 (5)
  6. 2020 (4)

More Years

Publications
  1. Leukemia and Lymphoma (22)
  2. Expert Review of Anticancer Therapy (1)
  3. Expert Review of Hematology (1)

Results (24)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era: Insights from a retrospective analysis
    Journal Article

    Luttwak, E.; Robin, E. T.; Drill, E.; Boardman, A.; Caron, P.; Epstein-Peterson, Z.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; more...
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • HMA/VEN treatment modifications and associated outcomes in IDH-mutant AML
    Journal Article

    Chin, K. K.; Derkach, A.; Famulare, C.; Gupta, G. K.; Borge, P. D.; Geyer, M.; Goldberg, A. D.; Haque, T.; Park, J. H.; Roeker, L. E.; more...
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • Trends in location of death for individuals with acute myeloid leukemia in the United States
    Research Letter

    Jain, U.; Rahim, F.; Jain, B.; Tresa Mathew, A.; Feliciano, E. J. G.; Dee, E. C.; Lapen, K.; Lee, F.; Chino, F.; Tremblay, D.; more...
    Leukemia and Lymphoma (2024)

    Fulltext@MSK | Save
  • TP53 Y220C mutations in patients with myeloid malignancies
    Research Letter

    Gener-Ricos, G.; Bewersdorf, J. P.; Loghavi, S.; Bataller, A.; Goldberg, A. D.; Sasaki, K.; Famulare, C.; Takahashi, K.; Issa, G. C.; Borthakur, G.; more...
    Leukemia and Lymphoma (2024)

    Fulltext@MSK | Save
  • Dermatologic adverse events in acute lymphocytic leukemia patients treated with bispecific T-cell engager blinatumomab
    Research Letter

    Parisi, R.; Cowen, E. A.; Gu, S.; Dusza, S.; Pulitzer, M.; Geyer, M. B.; King, A. C.; Markova, A.
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Venetoclax-based salvage therapy in patients with relapsed/refractory acute myeloid leukemia previously treated with FLT3 or IDH1/2 inhibitors
    Journal Article

    Bewersdorf, J. P.; Shallis, R. M.; Derkach, A.; Goldberg, A. D.; Stein, A.; Stein, E. M.; Marcucci, G.; Zeidan, A. M.; Shimony, S.; DeAngelo, D. J.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Targeting the immune microenvironment in mantle cell lymphoma: Implications for current and emerging therapies
    Review

    Qualls, D.; Kumar, A.; Epstein-Peterson, Z. D.
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • A phase 1b study of atezolizumab in combination with guadecitabine for the treatment of acute myeloid leukemia
    Journal Article

    Prebet, T.; Goldberg, A. D.; Jurcic, J. G.; Khaled, S.; Dail, M.; Feng, Y.; Green, C.; Li, C.; Ma, C.; Medeiros, B. C.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Successful implementation of outpatient R ± DHAX (rituximab, dexamethasone, oxaliplatin, cytarabine) for select patients with lymphoma: A single-center experience
    Journal Article

    Pak, T. K.; Dixon, B. N.; Buege, M. J.; Dao, P. H.; Leary, M. H.; Jarrett, J. C.; Duggan, T. A.; Caron, P.; Falchi, L.; Hamlin, P.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant
    Journal Article

    Bewersdorf, J. P.; Derkach, A.; Gowda, L.; Menghrajani, K.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; more...
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save